The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
BAP1/ASXL1 recruitment and activation for H2A deubiquitination
Open accessAbstract
The deubiquitinating enzyme BAP1 is an important tumor suppressor that has drawn attention in the clinic since its loss leads to a variety of cancers. BAP1 is activated by ASXL1 to deubiquitinate mono-ubiquitinated H2A at K119 in Polycomb gene repression, but the mechanism of this reaction remains poorly defined. Here we show that the BAP1 C-terminal extension is important for H2A deubiquitination by auto-recruiting BAP1 to nucleosomes in a process that does not require the nucleosome acidic patch. This initial encounter-like complex is unproductive and needs to be activated by the DEUBAD domains of ASXL1, ASXL2 or ASXL3 to increase BAP1’s affinity for ubiquitin on H2A, to drive the deubiquitination reaction. The reaction is specific for Polycomb modifications of H2A as the complex cannot deubiquitinate the DNA damage-dependent ubiquitination at H2A K13/15. Our results contribute to the molecular understanding of this important tumor suppressor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bott, M., Brevet, M., Taylor, B. S., Shimizu, S., Ito, T., Wang, L., Creaney, J., Lake, R. A., Zakowski, M. F., Reva, B., et al. (2011) · Nature Genetics · doi:10.1038/ng.855 · Cited by 717
Cited by
Mechanisms of Deubiquitinase Specificity and Regulation
Mevissen, T. E. T., & Komander, D. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044916 · Cited by 1,027
Deubiquitylating enzymes and drug discovery: emerging opportunities
Harrigan, J. A., Jacq, X., Martin, N. M., & Jackson, S. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.152 · Cited by 940
Breaking the chains: deubiquitylating enzyme specificity begets function
Clague, M. J., Urbé, S., & Komander, D. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0099-1 · Cited by 832
Deubiquitinases: From mechanisms to their inhibition by small molecules
Lange, S. M., Armstrong, L. A., & Kulathu, Y. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.10.027 · Cited by 332
Asbestos: Modern Insights for Toxicology in the Era of Engineered Nanomaterials
Felley-Bosco, E., & MacFarlane, M. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00146 · Cited by 23
MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer
Tsuboyama, N., Szczepanski, A. P., Zhao, Z., & Wang, L. (2022) · Genome Biology · doi:10.1186/s13059-022-02776-x · Cited by 21
Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding
Burgess, A. E., Kleffmann, T., & Mace, P. D. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167242 · Cited by 12
Unconventional structure and function of PHD domains from additional sex combs‐like proteins
Reddington, C. J., Walsh, A. R., Kleffmann, T., Göbl, C., & Mace, P. D. (2025) · The FEBS Journal · doi:10.1111/febs.70206 · Cited by 2
Metadata
- Authors
- Sahtoe, D. D., van Dijk, W. J., Ekkebus, R., Ovaa, H., & Sixma, T. K.
- Venue
- Nature Communications
- Published
- 2016-01-07
- Volume
- 7
- Issue
- 1
- Pages
- 10292-10292
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2272704264
- Cited by
- 225
- References
- 1
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.